Journal of Bacteriology, September 2001, p. 5311-5316, Vol. 183, No. 18
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.18.5311-5316.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Departments of Pathology1 and Microbiology/Immunology,5 University of Arkansas for Medical Sciences, and Central Arkansas Veterans Healthcare System,2 Little Rock, Arkansas, and Medical Research Service, Department of Veterans Affairs Medical Center, Long Beach,3 and Department of Medicine, California College of Medicine, University of California, Irvine,4 California
Received 19 March 2001/Accepted 11 June 2001
| |
ABSTRACT |
|---|
|
|
|---|
Among the products that are expressed when Mycobacterium tuberculosis undergoes hypoxic shiftdown to nonreplicating persistence (NRP) is the alpha-crystallin chaperone protein homologue (Acr). This expression coincides with the previously reported appearance of a respiratory type of nitrate reductase activity, the increase in glycine dehydrogenase activity, and the production of a unique antigen, URB-1. In a timed sampling study, using a slowly stirred oxygen depletion culture model, we have demonstrated that the hspX mRNA that codes for Acr protein as well as the protein itself is induced just as the bacilli enter the microaerophilic NRP stage 1 (NRP-1). In contrast to the induction observed for hspX mRNA, levels of 16S rRNA, fbpB mRNA (encoding the 85B alpha antigen), and aroB mRNA (encoding dehydroquinate synthase) demonstrate relatively small to no change upon entering NRP-1. Acr protein was shown to be identical to URB-1 by Western analysis with anti-URB-1 antibody. The fact that antibody to Acr is found in a high percentage of tuberculosis patients suggests that the hypoxic shiftdown of tubercle bacilli to the NRP state that occurs in vitro, resulting in production of the alpha-crystallin protein, occurs in vivo as well. Simultaneous abrupt increases in hspX mRNA and Acr protein suggest that Acr protein expression is controlled at the level of transcription.
| |
INTRODUCTION |
|---|
|
|
|---|
A major impediment to the control and eradication of tuberculosis is the ability of the tubercle bacillus to persist for long periods in a nonreplicating state in which it does not appear to be susceptible to the action of many antimycobacterial agents (18). More than one-third of the world's population is infected with Mycobacterium tuberculosis, and reactivation of latent disease is of increasing importance. This is especially true among individuals with declining immune systems, including the elderly and persons with AIDS (18). An increased understanding of such latency is needed in the development of new treatment strategies. It has been proposed that adaptation to depletion of available oxygen plays a significant role in the ability of M. tuberculosis to enter this state of nonreplicating persistence (NRP) (17). Abrupt depletion of oxygen is known to cause death and autolysis of tubercle bacilli (19), but gradual depletion induces a shiftdown to a state in which the bacilli can survive microaerophilic and anaerobic conditions (22), such as those that occur in granulomatous or necrotic lesions of the lung. A model of this process utilizing slowly stirred sealed cultures has been developed which demonstrates that the shiftdown of M. tuberculosis occurs in two stages, a microaerophilic nonreplicating stage, referred to as NRP-1, followed by an anaerobic nonreplicating stage, NRP-2, and events that occur during the microaerophilic stage appear to be critical to their ultimate hypoxic survival (20).
Several physiologic changes occur when aerobically growing bacilli are exposed to gradual limitations of available oxygen and enter into NRP-1. These include termination of replication and DNA synthesis (20) but with a continuing enlargement of the cells associated with cell wall thickening (3, 20), at least a 10-fold increase in activity of an enzyme that reductively aminates glyoxylate to glycine (glycine dehydrogenase), with concomitant regeneration of NAD from NADH (20, 22), appearance of a respiratory type of nitrate reductase activity (21), and production of a novel antigen, originally designated URB-1 (23). The URB-1 antigen has been considered to correspond to the 16-kDa alpha-crystallin chaperone protein homologue (Acr), although this has never been established (3, 25, 26).
Acr protein is of special interest not only because of its physiologic functions in tubercle bacilli (22, 26) but also because there is immunologic evidence that this protein is produced by tubercle bacilli in the human host (16, 24). This protein is produced only after exposure of tubercle bacilli to hypoxia and nitric oxide precursors in vitro but not to a number of other stress conditions (8, 25). It is also produced after ingestion by ThP-1 macrophage-like cells (26). All of these observations suggest that the hypoxic in vitro model of shiftdown reflects events that occur as M. tuberculosis shifts down to the nonreplicating state in vivo as well. This has prompted us to explore the actual induction of Acr protein and its mRNA in the slowly stirred hypoxic shiftdown model and compare the hspX mRNA expression profile to genomic DNA content and levels of 16S rRNA (a stable and abundant structural RNA). In addition, levels of fbpB and aroB mRNA were examined in this model. The fbpB gene encodes the 85B protein (alpha antigen), which functions as a mycolyl transferase in cell wall biosynthesis and is a dominant protein in mycobacterial culture filtrates (1) and which is presently a target in vaccine development strategies (11). The aroB gene encodes dehydroquinate synthase, an enzyme (AroB) involved in aromatic amino acid biosynthesis, and is believed to be an essential gene (9).
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cultivation of M. tuberculosis in the hypoxic
shiftdown model.
The H37Rv strain of M. tuberculosis
was grown in tubes of Dubos Tween-albumin broth (DTA) (Difco, Detroit,
Mich.) in the slowly stirred 0.5 headspace ratio (HSR) model of Wayne
and Hayes (20). Briefly, aerobically growing broth
cultures were inoculated to a set of 20- by 125-mm screw-cap culture
tubes containing 17 ml of DTA and an 8-mm Teflon-coated magnetic
stirring bar, resulting in a headspace of 8.5 ml of air; i.e., the
volumetric ratio of air to medium was 0.5. The calculated initial
optical density at 580 nm (OD580) was 0.004. The
tightly sealed cultures were placed in a rack on a low-speed magnetic
tissue culture stirrer at 120 rpm in a 37°C incubator. At designated
times individual cultures were removed, the OD580
was measured, and 15 ml of the culture was concentrated to a 1.0-ml
volume by centrifugation and quickly frozen and stored at
70°C
until it was used for isolation of nucleic acids.
Isolation of mycobacterial DNA and RNA.
Nucleic acids were
isolated from freshly thawed culture samples that were processed
simultaneously. RNA was isolated by organic extraction coupled with
mechanical disruption as described by DesJardin et al. (4,
7). DNA was isolated from the same aliquots as used for RNA
isolation, using a differential extraction protocol of the interface
and organic portions remaining after RNA isolation (5).
Controls for efficiency of DNA and RNA recovery, consisting of
standardized broth cultures of M. tuberculosis with known
colony counts, were included with each series of isolations (7). Two independent nucleic acid isolations were
performed per culture sample, and the nucleic acids were stored at
70°C until tested.
Quantification of nucleic acids using the ABI 7700 (TaqMan). (i)
TaqMan technology.
Amplification and quantification of specific
mycobacterial DNA and cDNA products were performed using the real-time
PCR format of the ABI Prism 7700 Sequence Detection System
(ABI/Perkin-Elmer, Foster City, Calif.). Sequences of the
oligonucleotide primers and detector probe (TaqMan probes) specific for
each target are listed in Table 1. The
internal oligonucleotide TaqMan probes were fluorescently labeled on
the 5' end with 5-carboxyfluoroscein (FAM) and
N,N,N',N'-tetramethyl-6-carboxyrhodamine
(TAMRA) on the 3' end (Synthegen, Houston, Tex.). When the two dyes are
in close proximity, as with an intact oligonucleotide probe, TAMRA acts
as a quencher for FAM by absorbing at the FAM emission spectra. The 5'
exonuclease activity of Taq polymerase degrades the
internally hybridizing probe during the course of PCR
(13), and degradation of the probe leads to separation of
these two dyes in solution, with a subsequent increase in the level of
fluorescence in the reaction mixture. The amount of fluorescence
measured in a sample is proportional to the amount of specific PCR
product generated (5, 10, 12). The TAMRA emission spectrum
was used to standardize for background fluorescence (18).
The threshold value of fluorescence for a positive PCR (cycle
threshold, CT) was set at 10 times the standard
deviation of the mean baseline emission between cycles 3 and 15 of
amplification. The quantity of DNA and cDNA in each reaction was
determined from the CT value with reference to a standard curve generated by amplification of known amounts of target
DNA or RNA (converted to cDNA). As reported previously for the
IS6110 DNA TaqMan assay (5), the standard
curves for the RNA targets were linear over 5 orders of magnitude, with
an intra- or interassay coefficient of variation of less than 10% with
standards.
|
(ii) PCR conditions. PCR conditions were nearly identical for all of the assays. The 50-µl reaction mixture consisted of 1× PCR Buffer II (Perkin-Elmer), 3 mM MgCl2, 200 µM concentrations of each deoxynucleoside triphosphate (dATP, dCTP, and dGTP), 400 µM dUTP, 0.5 U of uracil DNA glycosylase, 1 U of Taq polymerase (ISC Bioexpress, Kaysville, Utah) or AmpliTaq Gold polymerase for 16S rRNA (Perkin-Elmer), 0.2 µM concentrations of each primer, and a 0.1 µM concentration of the TaqMan probe. The PCR profile consisted of 1 cycle at 50°C (for uracil DNA glycosylase decontamination) for 2 min, 1 cycle at 95°C for 5 min, and 45 cycles of 94°C for 30 s and 68°C for 1 min. PCR primers for all of the targets were designed to hybridize only to M. tuberculosis complex strains. These assays were determined to be specific for M. tuberculosis complex organisms by screening with a panel of 42 mycobacterial species and related genera (data not shown).
(iii) IS6110 PCR. DNA samples were tested in the ABI quantitative IS6110 PCR assay as previously described (5). These values were used to calculate the number of mycobacterial genomes per sample (the number of IS6110 DNA molecules was divided by 16, which is the number of copies of the IS6110 sequence in M. tuberculosis strain H37Rv [2]).
(iv) RT-PCR. RNA was reverse transcribed using avian myeloblastosis virus reverse transcriptase in a 20-µl reaction volume for all three mRNA targets simultaneously and in a separate reaction mixture for 16S rRNA as described previously (6). After reverse transcription (RT), the amount of cDNA obtained from each RNA species was measured by PCR with TaqMan probes in separate reactions. The amount of contaminating chromosomal DNA was tested in parallel reactions without reverse transcriptase. No contamination was observed in these samples.
The efficiency of RT was determined for each assay by using in vitro transcripts of cloned M. tuberculosis fbpB, aroB, hspX, and 16S rRNA genes. In vitro transcripts were generated from pBlueScript with the T3 RNA polymerase promoter (Stratagene, La Jolla, Calif.) using a MAXIscript T3 Kit (Ambion, Austin, Tex.) according to the manufacturer's instructions. Transcripts were determined to be of the correct size by denaturing gel electrophoresis and were quantified by spectrophotometry. Dilutions of control transcripts ranging from 102 to 106 molecules/µl in 10 ng of yeast carrier RNA (Ambion)/µl were included in each RT-PCR assay. The efficiency of RT was determined by calculating the ratio of the number of observed to the number of expected molecules per reaction. Typical efficiencies were approximately 10% for fbpB and aroB, 3% for hspX, and 3% for 16S rRNA. The number of molecules of mRNA per sample was calculated by correcting for the efficiency of RT and the dilution factors involved in the reverse transcriptase reaction and PCR.Protein analysis. M. tuberculosis cultures were sonicated as previously described (22, 23) and then centrifuged at 10,000 × g for 5 min before filtration through a 0.2-µm filter (Corning, Corning, N.Y.). Protein concentration was determined by the Bradford assay (Bio-Rad, Hercules, Calif.). Twenty micrograms of protein for each sample was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using a Tris-tricine 16.5% polyacrylamide gel (Bio-Rad). The gel was stained and the protein was transferred to a nitrocellulose paper (Schleicher & Schuell, Keene, N.H.) for Western blotting. The primary antibody was either CS49 (16), in which case the secondary antibody was goat anti-mouse horseradish peroxidase-conjugated antibody (Santa Cruz Biotechnology, Santa Cruz, Calif.), or the primary antibody was RS88-13078 (23), in which case the secondary antibody was goat anti-rabbit horseradish peroxidase-conjugated antibody (ICN ImmunoBiologicals, Lisie, Ill.).
| |
RESULTS |
|---|
|
|
|---|
Cultures of M. tuberculosis H37Rv grown under oxygen
depletion conditions exhibited the characteristic three-stage optical density pattern (Fig. 1), corresponding
to the initial aerobic logarithmic growth phase for about 60 h,
followed by a shiftdown to the microaerophilic NRP-1 stage (in which
replication stopped but the OD580 continued to
rise at a reduced rate) and finally the abrupt deflection at
approximately 160 h to the anaerobic plateau of the NRP-2 stage.
The increase in genomic DNA content of successive samples (Fig. 1)
coincided with the increase in turbidity (OD580)
of the cultures up to the time of first deflection into NRP-1; at that
point, the DNA content stopped rising, thus confirming termination of
replication of bacilli at that deflection. Neither an increase in
OD580 nor an increase in DNA content was observed
after entry into the anaerobic NRP-2 stage.
|
Changes in the amounts of different messages (mRNA) during cultivation,
expressed as molecules per genome to compensate for the bacillary
replication during the aerobic phase and termination on entry into
NRP-1 as well as to correct for any possible losses during centrifugal
concentration of the bacterial suspensions, are shown in Fig.
2A. The number of hspX mRNA
molecules per genome increased approximately 100-fold upon transition
from aerobic log phase growth into the microaerophilic NRP-1 stage and
leveled off as the bacilli enter the anaerobic NRP-2 stage. This is in contrast to a stable number (5.5 × 103 ± 2.1 × 103) of 16S rRNA molecules per genome
throughout the three growth phases.
|
The amount of message of fbpB, a gene encoding antigen 85B that functions as a mycolyltransferase in cell wall biosynthesis (1), was increased about fivefold in the microaerophilic NRP-1 stage over that seen aerobically (Fig. 2A) and remained at this level in the anaerobic NRP-2 state. The number of molecules of aroB mRNA, which encodes dehydroquinate synthase, decreased an order of magnitude as the bacilli shifted into the microaerophilic NRP-1 stage (Fig. 2A), and this lower amount remained constant in the anaerobic NRP-2. The changes in numbers of molecules per genome of hspX, fbpB, and aroB mRNA during cultivation with limited or no oxygen were supported when expressed as a ratio of mRNA to 16S rRNA content to compensate for the lesser stability of RNA compared to that of DNA and control for the efficiency of RNA isolation (Fig. 2B).
To further investigate the dramatic induction of hspX mRNA
at the point of shiftdown into the NRP-1 state, we examined Acr protein
expression throughout the time course of the oxygen depletion model. No
Acr protein was observed in protein profiles from aerobic cultures or
those before microaerophilic shiftdown but was first seen in the 67-h
sample at about the time of entry into NRP-1 (Fig.
3A). The amount of Acr protein increased
as the culture progressed further through NRP-1 into NRP-2. Acr
expression within a few hours after the initiation of the shift of the
culture into NRP-1 coincides with the induction of hspX
mRNA. A Western blot with anti-Acr antibody confirmed the identity of
the Acr band (data not shown).
|
To determine if the Acr protein and the URB-1 protein were identical, Western blot analysis was done with anti-URB-1 polyclonal antibody and the Acr monoclonal antibody. The Acr antibody identified a single protein (Fig. 3B), while the URB-1 antibody reacted with several proteins. URB-1 was originally identified as an antigen absent in aerobically growing cells but present after hypoxic incubation (23). There is a single protein band present in the NRP-1 culture but missing from the aerobic culture that separates with the same approximate molecular weight as the Acr protein, suggesting that URB-1 and Acr are the same protein.
| |
DISCUSSION |
|---|
|
|
|---|
The data presented here indicate a very abrupt induction of the hspX mRNA at the point of termination of replication and DNA synthesis of tubercle bacilli that corresponds to their entry into microaerophilic NRP-1; i.e., when dissolved oxygen levels have dropped below 10% air saturation equivalence and rapidly approached 1% of their initial saturation level (20). This coincides with the point of rapid acceleration of expression of the enzyme responsible for reductive amination of glyoxylate (glycine dehydrogenase) (20) and of the respiratory nitrate reductase (21). Furthermore, the ongoing rise in concentration of hspX mRNA appears to terminate just before the culture becomes sufficiently anaerobic to enter NRP-2, which is below 0.06% air saturation equivalence (20). In view of the relative instability of the hspX mRNA, with a half-life of only 2 min (14), the persistent plateau level of this transcript suggests equilibrium between decay and low-level synthesis throughout NRP-1 and well into NRP-2. The Acr protein, on the other hand, is relatively stable (25) and was found to be at high levels into NRP-2. Its accumulation, as seen on SDS-PAGE, mirrors the transcription of hspX mRNA. Further support for our observations was recently reported by Boon et al. (1a), who used the slowly stirred shiftdown model to examine dormancy-induced proteins of Mycobacterium bovis BCG. Levels of Acr protein dramatically increased as the BCG entered the hypoxic state and remained elevated throughout the hypoxic stationary phase. This steady-state level of Acr correlated with an increase in the steady-state level of hspX mRNA, suggesting that Acr is regulated at the transcriptional level.
There is an apparent discrepancy between our observations on the timing of transcription and translation of hspX and those reported by Hu and Coates (14). Using a modification of the unstirred settling hypoxic shiftdown model originally described by Wayne and Lin (17, 22), they concluded that the induction of hspX mRNA started during aerobic logarithmic growth and terminated during the microaerophilic stage. On the other hand, levels of Acr protein were not detected until oxygen was severely depleted (25, 26). Thus, Hu and Coates hypothesized an inverse relationship between transcriptional and posttranscriptional control of Acr protein levels. No growth curve data were presented in their report to establish the physiologic stages of the cultures used for the hspX mRNA assays, but based on data from the two papers cited earlier (17, 22), they concluded that a 4-day-old unstirred culture was still in mid-log growth phase. However, it is not the temporal age of a culture in the hypoxic model that determines the physiologic stage but rather the cell density and associated rate of depletion of dissolved oxygen (20). In the original work with unstirred cultures the medium was inoculated with about 1.2 × 106 CFU/ml (17, 22), whereas Hu and Coates started with unstirred cultures representing a 1:10 dilution of a 10-day-old culture, suggesting that their initial inoculum was at least an order of magnitude greater. In a subsequent paper in which their modified settling model was used again, Hu and colleagues recorded (15) a 200-fold depletion of dissolved oxygen in the bottom of the culture after only 24 h of incubation. Thus, a significant fraction of the population of bacilli at or near the bottom of the container by the fourth day was subjected to severe hypoxic conditions, so the whole unstirred 4-day-old culture comprised a physiologically mixed population in a self-generated oxygen gradient (17). Our data demonstrate that the hypoxic component of the population would have been responsible for the presence of the hspX mRNA at that time in the Hu and Coates model, and from this we may infer that the half-life reported by Hu and Coates (14) does correspond to that of the hypoxically induced transcript.
Although the most dramatic finding in this study is the significant increase in hspX mRNA, there was also a small increase in transcription of the fbpB mRNA. This gene encodes the 85B mycolyl transferase protein that is involved in cell wall biosynthesis (1), prompting speculation that this product may play a role in the cell wall thickening demonstrated by electron microscopy in cells of tubercle bacilli in microaerophilic NRP-1 but not in old nonreplicating cultures that were subjected to continuing aeration (3). It is also of interest that aroB mRNA decreases as the bacilli enter limiting oxygen conditions. With its role as a biosynthetic enzyme in the shikimate pathway (9), one could speculate that as the tubercle bacilli shift down to the nonreplicating phase there is decreasing need for de novo protein synthesis, thus the observed decrease in aroB mRNA.
Acr has been shown, through the use of a reporter gene construct, to be induced upon entrance of M. tuberculosis into the macrophage-like THP-1 cell line, and tubercle bacilli whose hspX genes have been disrupted are attenuated for growth within those cells (26). It has also been reported (25) that tubercle bacilli engineered to overexpress the Acr protein grew much slower than the wild strain in culture. Yuan and associates hypothesized that expression of Acr was responsible for this low growth rate and that down-regulation of this gene was necessary to achieve replication of M. tuberculosis at its normal rate (25). Wayne and Lin (22) noted that resumption of aeration of cultures in the NRP state resulted in dilution of the URB-1 antigen, which corresponds to Acr, with freshly synthesized protein; the loss of tolerance of the bacilli to anaerobic conditions paralleled the reduction in specific activity of Acr in the bacilli during this aerobic shiftup.
At least 85% of a series of tuberculosis patients have been shown to have antibody to the Acr protein of M. tuberculosis, demonstrating that it is ubiquitous in infected individuals (16). Since inflammatory, granulomatous, and necrotic lesions have hypoxic regions (22a), the hypoxic shiftdown to NRP seen with this organism in vitro suggests that this probably occurs in the human host as well. Within this context, monitoring the ratio of concentration of the Acr mRNA to that of the 85B mRNA in tissues of experimentally infected animals or sputum specimens of tuberculosis patients may be a useful means for assessing the temporal relationship between the emerging immunologic response of the host and changes in the physiologic state of the tubercle bacilli. It should be noted that Garbe and colleagues (8) have reported that precursors to nitric oxide, which is produced by macrophages, can also induce production of Acr by tubercle bacilli; details of the physiologic state of the bacilli used to induce that effect were not presented. Nevertheless, there may indeed be alternative mechanisms by which the protective Acr is induced.
Our results are consistent with previous studies showing that Acr protein is not detected until aerobic growth has terminated (1a, 25, 26). The induction of Acr during hypoxic shiftdown, its function as a chaperone (26), its location in the cell wall (3), the negative effect of its overexpression on growth rate (26), and the correlation of its cellular concentration with tolerance of tubercle bacilli to abrupt anaerobic shock (22) all suggest a critical role for this product in the ability of M. tuberculosis to persist without replicating in hostile regions of the host's tissues. An understanding of the mechanisms of induction of factors associated with the hypoxic shiftdown tubercle bacilli should contribute to the development of strategies for preventing that persistence.
| |
ACKNOWLEDGMENTS |
|---|
The study reported here was supported by contract NO-AI-45244 from the National Institutes of Health, Tuberculosis Research Unit, and by the Medical Research Service of the Department of Veterans Affairs.
We are grateful to Chris Hemphill, Robert Pruss, Sandra Sudberg, and Maria Winters for expert technical assistance. We thank John Spencer and John Belisle for the anti-Acr antibody and technical advice.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Central Arkansas Veterans Healthcare System, Medical Research Service, Slot 151, 4300 W. 7th St., Little Rock, AR 72205-5484. Phone: (501) 257-4827. Fax: (501) 664-6748. E-mail: eisenachkathleend{at}uams.edu.
Present address: University of Iowa, Department of Medicine,
Division of Infectious Diseases and Veterans Affairs Medical Center,
Iowa City, IA 52246.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Belisle, J. T.,
V. D. Vissa,
T. Sievert,
K. Takayama,
P. J. Brennan, and G. S. Besra.
1997.
Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis.
Science
276:1420-1422 |
| 1a. |
Boon, C.,
R. Li,
R. Qi, and T. Dick.
2001.
Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model.
J. Bacteriol.
183:2672-2676 |
| 2. | Cole, S. T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry III, F. Tekaia, K. Badcock, O. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, A. Krogh, J. McLean, S. Moule, L. Murphy, K. Oliver, J. Osborne, M. A. Quail, M.-A. Rajandream, J. Rogers, S. Rutter, K. Seeger, J. Skelton, R. Squares, S. Squares, J. E. Sulston, T. Taylor, S. Whitehead, and B. G. Barrell. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-544[CrossRef][Medline]. |
| 3. |
Cunningham, A. F., and C. L. Spreadbury.
1998.
Mycobacterial stationary phase induced by low oxygen tension: cell wall thickening and localization of the 16-kilodalton -crystallin homolog.
J. Bacteriol.
180:801-808 |
| 4. | Desjardin, L. E. Isolation of Mycobacterium tuberculosis RNA from sputum. In S. H. Gillespie (ed.), Antibiotic resistance methods and protocols. Humana Press, Totowa, N.J., in press. |
| 5. |
Desjardin, L. E.,
Y. Chen,
M. D. Perkins,
L. Teixeira,
M. D. Cave, and K. D. Eisenach.
1998.
Comparison of the ABI 7700 system (TaqMan) and competitive PCR for quantification of IS6110 in sputum during treatment for tuberculosis.
J. Clin. Microbiol.
36:1964-1968 |
| 6. | Desjardin, L. E., M. D. Perkins, L. Teixeira, M. D. Cave, and K. D. Eisenach. 1996. Alkaline decontamination of sputum specimens adversely affects stability of mycobacterial mRNA. J. Clin. Microbiol. 34:2435-2439[Abstract]. |
| 7. |
Desjardin, L. E.,
M. D. Perkins,
K. Wolski,
S. Haun,
L. Teixeira,
Y. Chen,
J. L. Johnson,
J. J. Ellner,
R. Dietze,
J. Bates,
M. D. Cave, and K. D. Eisenach.
1999.
Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy.
Am. J. Respir. Crit. Care Med.
160:203-210 |
| 8. |
Garbe, T. R.,
N. S. Hibler, and V. Deretic.
1999.
Response to reactive nitrogen intermediates in Mycobacterium tuberculosis: induction of the 16-kilodalton -crystallin homolog by exposure to nitric oxide donors.
Infect. Immun.
67:460-465 |
| 9. | Garbe, T. R., S. Servos, A. Hawkins, G. Demetriadis, D. Young, G. Dougan, and I. Charles. 1991. The Mycobacterium tuberculosis shikimate pathway genes: evolutionary relationship between biosynthetic and catabolic 3-dehydroquinases. Mol. Gen. Genet. 228:382-392. |
| 10. |
Gibson, U. E. M.,
C. A. Heid, and P. M. Williams.
1996.
A novel method for real time quantitative RT-PCR.
Genome Res.
6:995-1001 |
| 11. | Harth, G., B. Y. Lee, and M. A. Horwitz. 1998. High-level heterologous expression and secretion in rapidly growing nonpathogenic mycobacteria of four major Mycobacterium tuberculosis extracellular proteins considered to be leading vaccine candidates and drug targets. Infect. Immun. 65:2321-2328[Abstract]. |
| 12. |
Heid, C. A.,
J. Stevens,
K. J. Livak, and P. M. Williams.
1996.
Real time quantitative PCR.
Genome Res.
6:986-994 |
| 13. |
Holland, P. M.,
R. D. Abramson,
R. Watson, and D. H. Gelfand.
1991.
Detection of specific polymerase chain reaction product by utilizing the 5'*3' exonuclease activity of Thermus aquaticus DNA polymerase.
Proc. Natl. Acad. Sci. USA
88:7276-7280 |
| 14. |
Hu, Y. M., and A. R. M. Coates.
1999.
Transcription of the stationary-phase-associated hspX gene of Mycobacterium tuberculosis is inversely related to synthesis of the 16-kilodalton protein.
J. Bacteriol.
181:1380-1387 |
| 15. |
Hu, Y. M.,
P. D. Butcher,
J. A. Mangan,
M.-A. Rajandream, and A. R. M. Coates.
1999.
Regulation of hmp gene transcription in Mycobacterium tuberculosis: effects of oxygen limitation and nitrosative and oxidative stress.
J. Bacteriol.
181:3486-3493 |
| 16. |
Lee, B.-Y.,
S. A. Hefta, and P. J. Brennan.
1992.
Characterization of the major membrane protein of virulent Mycobacterium tuberculosis.
Infect. Immun.
60:2066-2074 |
| 17. | Wayne, L. G. 1976. Dynamics of submerged growth of Mycobacterium tuberculosis under aerobic and microaerophilic conditions. Am. Rev. Respir. Dis. 114:807-811[Medline]. |
| 18. | Wayne, L. G. 1994. Dormancy of Mycobacterium tuberculosis and latency of disease. Eur. J. Clin. Microbiol. Infect. Dis. 13:908-914[CrossRef][Medline]. |
| 19. |
Wayne, L. G., and G. A. Diaz.
1967.
Autolysis and secondary growth of Mycobacterium tuberculosis in submerged culture.
J. Bacteriol.
93:1374-1381 |
| 20. | Wayne, L. G., and L. G. Hayes. 1996. An in vitro model for the sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect. Immun. 64:2062-2069[Abstract]. |
| 21. | Wayne, L. G., and L. G. Hayes. 1998. Nitrate reduction as a marker for hypoxic shiftdown of Mycobacterium tuberculosis. Tuber. Lung Dis. 79:127-132[CrossRef][Medline]. |
| 22. |
Wayne, L. G., and K.-Y. Lin.
1982.
Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions.
Infect. Immun.
37:1042-1049 |
| 22a. | Wayne, L. G., and C. D. Sohaskey. Nonreplicating persistence of Mycobacterium tuberculosis. Annu. Rev. Microbiol., in press. |
| 23. |
Wayne, L. G., and H. A. Sramek.
1979.
Antigenic differences between extracts of actively replicating and synchronized resting cells of Mycobacterium tuberculosis.
Infect. Immun.
24:363-370 |
| 24. |
Wilkinson, R. J.,
K. A. Wilkinson,
K. A. L. De Smet,
K. Haslov,
G. Pasvol,
M. Singh,
I. Svarcova, and J. Ivanyi.
1998.
Human T- and B-cell reactivity to the 16 kDa -crystallin protein of Mycobacterium tuberculosis.
Scand. J. Immunol.
48:403-409[CrossRef][Medline].
|
| 25. |
Yuan, Y.,
D. D. Crane, and C. E. Barry, III.
1996.
Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial -crystallin homolog.
J. Bacteriol.
178:4484-4492 |
| 26. |
Yuan, Y.,
D. D. Crane,
R. M. Simpson,
Y.-Q. Zhu,
M. J. Hickey,
D. R. Sherman, and C. E. Barry, III.
1998.
The 16-kDa -crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages.
Proc. Natl. Acad. Sci. USA
95:9578-9583 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |